{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:02:04Z","timestamp":1790870524749,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2510580"],"award-info":[{"award-number":["2510580"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.msard.2025.106534","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:12:50Z","timestamp":1748002370000},"page":"106534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neurofilament light chain predict disease activity and disability Progression in Korean patients with multiple sclerosis"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6428-061X","authenticated-orcid":false,"given":"Ki Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ho","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Ri","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-0918","authenticated-orcid":false,"given":"Su-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2025.106534_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105747","article-title":"Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: a 6-year follow-up","volume":"89","author":"Ayrignac","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2025.106534_bib0002","article-title":"Serum glial fibrillary acidic protein and neurofilament light chain levels reflect different mechanisms of disease progression under B-cell depleting treatment in multiple sclerosis","author":"Benkert","year":"2024","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106534_bib0003","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"issue":"11\u201312","key":"10.1016\/j.msard.2025.106534_bib0004","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1177\/13524585231198751","article-title":"Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis","volume":"29","author":"Bose","year":"2023","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2025.106534_bib0005","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1177\/1352458520972573","article-title":"Temporal profile of serum neurofilament light in multiple sclerosis: implications for patient monitoring","volume":"27","author":"Calabresi","year":"2021","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2025.106534_bib0006","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2019.2137","article-title":"Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years","volume":"76","author":"Cant\u00f3","year":"2019","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.msard.2025.106534_bib0007","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/acn3.638","article-title":"Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis","volume":"5","author":"Chitnis","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.msard.2025.106534_bib0008","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2025.106534_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209357","article-title":"Temporal relationship between serum neurofilament light chain and radiologic disease activity in patients with multiple sclerosis","volume":"102","author":"Fox","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106534_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"issue":"10422","key":"10.1016\/j.msard.2025.106534_bib0011","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.msard.2025.106534_bib0012","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1177\/1352458519881428","article-title":"Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: a longitudinal retrospective 5-year study","volume":"26","author":"Jakimovski","year":"2020","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2025.106534_bib0013","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/13524585241237388","article-title":"Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: a 48-week prospective single-center study","volume":"30","author":"Johnsson","year":"2024","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.msard.2025.106534_bib0014","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders - towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.msard.2025.106534_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WCO.0000000000001262","article-title":"Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold","volume":"37","author":"Krieger","year":"2024","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106534_bib0016","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/13524585211032348","article-title":"Sustained reduction of serum neurofilament light chain over 7\u2009years by alemtuzumab in early relapsing-remitting MS","volume":"28","author":"Kuhle","year":"2022","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2025.106534_bib0017","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2025.106534_bib0018","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/jnnp-2021-328568","article-title":"Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study","volume":"93","author":"Lie","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"1","key":"10.1016\/j.msard.2025.106534_bib0019","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.50972","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"7","author":"Manouchehrinia","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"23","key":"10.1016\/j.msard.2025.106534_bib0020","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1212\/WNL.0000000000009571","article-title":"Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis","volume":"94","author":"Manouchehrinia","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2025.106534_bib0021","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2023.0010","article-title":"Association of serum neurofilament light chain levels at disease onset with disability worsening in patients with a first demyelinating multiple sclerosis event not treated with high-efficacy drugs","volume":"80","author":"Monreal","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.msard.2025.106534_bib0022","article-title":"Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis","volume":"15","author":"Rodr\u00edguez-Jorge","year":"2024","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.msard.2025.106534_bib0023","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/acn3.51060","article-title":"Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis","volume":"7","author":"Rosso","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.msard.2025.106534_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103535","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.msard.2025.106534_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2025.106534_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825002767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825002767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:40:47Z","timestamp":1762602047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825002767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"alternative-id":["S2211034825002767"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106534","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament light chain predict disease activity and disability Progression in Korean patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106534"}}